Literature DB >> 32032849

Protostane-type triterpenoids as natural soluble epoxide hydrolase inhibitors: Inhibition potentials and molecular dynamics.

Cheng-Peng Sun1, Juan Zhang2, Wen-Yu Zhao3, Jing Yi3, Jian-Kun Yan4, Ya-Li Wang5, Christophe Morisseau6, Zhong-Bo Liu7, Bruce D Hammock8, Xiao-Chi Ma3.   

Abstract

The inhibition of soluble epoxide hydrolase (sEH) is a promising therapeutic approach to treat inflammation and other disorders. In our present investigation on searching for sEH inhibitors from traditional Chinese medicines, we found that Alisma orientale displayed inhibition of sEH. We constructed a small library of protostane-type triterpenoids (1-25) isolated from A. orientale, and screened their inhibitory activities. Alismanin B (1), 11-deoxy-25-anhydro alisol E (4), 11-deoxy alisol B (5), and 25-O-ethyl alisol A (15) displayed concentration-dependently inhibitory activities against sEH with IC50 values from 3.40 ± 0.57 μM to 9.57 ± 0.88 μM. 11-Deoxy-25-anhydro alisol E (4) and 11-deoxy alisol B (5) were defined as mixed-type competitive inhibitors with Ki values of 12.6 and 3.48 μM, respectively, based on the result of inhibition kinetics. The potential interaction mechanism of 11-deoxy alisol B (5) with sEH was analyzed by molecular docking and molecular dynamics, revealing that amino acid residues Trp336 and Tyr466 were vital for its inhibitory activity.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inhibition kinetics; Molecular dynamics stimulation; Protostane-type triterpenoids; Soluble epoxide hydrolase

Year:  2020        PMID: 32032849      PMCID: PMC7233170          DOI: 10.1016/j.bioorg.2020.103637

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  36 in total

1.  Development of a high throughput cell-based assay for soluble epoxide hydrolase using BacMam technology.

Authors:  Wensheng Xie; Xiaoyan Tang; Quinn Lu; Robert S Ames; Steven J Ratcliffe; Hu Li
Journal:  Mol Biotechnol       Date:  2010-07       Impact factor: 2.695

2.  Computer-Aided Selective Optimization of Side Activities of Talinolol.

Authors:  Kerstin Hiesinger; Jan S Kramer; Janosch Achenbach; Daniel Moser; Julia Weber; Sandra K Wittmann; Christophe Morisseau; Carlo Angioni; Gerd Geisslinger; Astrid S Kahnt; Astrid Kaiser; Anna Proschak; Dieter Steinhilber; Denys Pogoryelov; Karen Wagner; Bruce D Hammock; Ewgenij Proschak
Journal:  ACS Med Chem Lett       Date:  2019-05-29       Impact factor: 4.345

3.  In silico investigation of cycloartane triterpene derivatives from Cimicifuga dahurica (Turcz.) Maxim. roots for the development of potent soluble epoxide hydrolase inhibitors.

Authors:  Nguyen Phuong Thao; Jang Hoon Kim; Bui Thi Thuy Luyen; Nguyen Tien Dat; Young Ho Kim
Journal:  Int J Biol Macromol       Date:  2017-02-07       Impact factor: 6.953

4.  cDNA cloning and expression of a soluble epoxide hydrolase from human liver.

Authors:  J K Beetham; T Tian; B D Hammock
Journal:  Arch Biochem Biophys       Date:  1993-08-15       Impact factor: 4.013

5.  Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.

Authors:  Kentaro Takai; Naoki Chiyo; Tomoko Nakajima; Tetsuro Nariai; Chihiro Ishikawa; Shogo Nakatani; Akihisa Ikeno; Setsuko Yamamoto; Toshihiko Sone
Journal:  Bioorg Med Chem Lett       Date:  2015-03-07       Impact factor: 2.823

6.  Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.

Authors:  Anne B Eldrup; Fariba Soleymanzadeh; Neil A Farrow; Alison Kukulka; Stéphane De Lombaert
Journal:  Bioorg Med Chem Lett       Date:  2009-11-22       Impact factor: 2.823

7.  Molecular cloning and expression of murine liver soluble epoxide hydrolase.

Authors:  D F Grant; D H Storms; B D Hammock
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

8.  EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.

Authors:  Martina Decker; Magdalena Adamska; Annette Cronin; Francesca Di Giallonardo; Julia Burgener; Anne Marowsky; John R Falck; Christophe Morisseau; Bruce D Hammock; Artiom Gruzdev; Darryl C Zeldin; Michael Arand
Journal:  J Lipid Res       Date:  2012-07-12       Impact factor: 5.922

Review 9.  Soluble Epoxide Hydrolase Inhibitor: A Novel Potential Therapeutic or Prophylactic Drug for Psychiatric Disorders.

Authors:  Qian Ren
Journal:  Front Pharmacol       Date:  2019-04-24       Impact factor: 5.810

10.  Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy.

Authors:  Kin Sing Stephen Lee; Jun-Yan Liu; Karen M Wagner; Svetlana Pakhomova; Hua Dong; Christophe Morisseau; Samuel H Fu; Jun Yang; Peng Wang; Arzu Ulu; Christina A Mate; Long V Nguyen; Sung Hee Hwang; Matthew L Edin; Alexandria A Mara; Heike Wulff; Marcia E Newcomer; Darryl C Zeldin; Bruce D Hammock
Journal:  J Med Chem       Date:  2014-08-11       Impact factor: 7.446

View more
  7 in total

1.  Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression.

Authors:  Anna Fishbein; Weicang Wang; Haixia Yang; Jun Yang; Victoria M Hallisey; Jianjun Deng; Sanne M L Verheul; Sung Hee Hwang; Allison Gartung; Yuxin Wang; Diane R Bielenberg; Sui Huang; Mark W Kieran; Bruce D Hammock; Dipak Panigrahy
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-14       Impact factor: 11.205

2.  N-Benzyl-linoleamide, a Constituent of Lepidium meyenii (Maca), Is an Orally Bioavailable Soluble Epoxide Hydrolase Inhibitor That Alleviates Inflammatory Pain.

Authors:  Nalin Singh; Bogdan Barnych; Christophe Morisseau; Karen M Wagner; Debin Wan; Ashley Takeshita; Hoang Pham; Ting Xu; Abhaya Dandekar; Jun-Yan Liu; Bruce D Hammock
Journal:  J Nat Prod       Date:  2020-12-15       Impact factor: 4.050

Review 3.  Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.

Authors:  Amarjyoti Das Mahapatra; Rinku Choubey; Bhaskar Datta
Journal:  Molecules       Date:  2020-11-24       Impact factor: 4.411

4.  Inhibitory Activity of Quaternary Isoquinoline Alkaloids on Soluble Epoxide Hydrolase.

Authors:  Jang Hoon Kim; Chong Woon Cho; Mok Hur; Woo Tae Park; Youn-Ho Moon; Sung-Cheol Koo; Yun-Chan Hur; Jong Seong Kang; Ik Soo Lee
Journal:  Curr Issues Mol Biol       Date:  2022-09-16       Impact factor: 2.976

Review 5.  Pharmacological Properties and Molecular Targets of Alisol Triterpenoids from Alismatis Rhizoma.

Authors:  Christian Bailly
Journal:  Biomedicines       Date:  2022-08-11

6.  Discovery of memantyl urea derivatives as potent soluble epoxide hydrolase inhibitors against lipopolysaccharide-induced sepsis.

Authors:  Fangyu Du; Wenjiao Sun; Christophe Morisseau; Bruce D Hammock; Xuefei Bao; Qiu Liu; Chao Wang; Tan Zhang; Hao Yang; Jun Zhou; Wei Xiao; Zhongbo Liu; Guoliang Chen
Journal:  Eur J Med Chem       Date:  2021-06-29       Impact factor: 6.514

Review 7.  Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical Synthesis and Natural Products.

Authors:  Cheng-Peng Sun; Xin-Yue Zhang; Christophe Morisseau; Sung Hee Hwang; Zhan-Jun Zhang; Bruce D Hammock; Xiao-Chi Ma
Journal:  J Med Chem       Date:  2020-12-28       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.